Soticlestat (Standard)
Soticlestat (Standard) is the analytical standard of Soticlestat (HY-109123). This product is intended for research and analytical applications. Soticlestat (TAK-935; OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor. Soticlestat has the potential for epilepsy syndromes research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1429505-03-2
- 화학식: C23H23N3O2
- 분자량:373.45
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- 순도&문서
-
Help & FAQs
-
HY-109123
SoticlestatCholesterol 24-hydroxylase Inhibitor -
HY-N2229
RhapontigeninCytochrome P450 1A1 Inactivator -
HY-B1232
Metyrapone11β-hydroxylase Inhibitor -
HY-103389
1-AminobenzotriazoleCytochrome P450 Inhibitor -
HY-14531
TalarozoleCYP26 Inhibitor/RAMBA -
HY-19340
TMSCYP1B1 Inhibitor -
HY-114759
MS-PPOHCYP Epoxygenase Inhibitor -
HY-N2229R
Rhapontigenin (Standard)Cytochrome P450 1A1 Inactivator -
HY-121188
DDMS20-HETE Inhibitor -
HY-101285
DMU2139CYP1B1 Inhibitor -
HY-B1232R
Metyrapone (Standard)11β-hydroxylase Inhibitor -
HY-14531R
Talarozole (Standard)CYP26 Inhibitor/RAMBA
Product Information
Information
신청
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1429505-03-2
-
분자량 373.45
-
화학식 C23H23N3O2
-
SMILES
O=C(N1CCC(CC2=CC=CC=C2)(O)CC1)C3=C(C4=CC=NC=C4)N=CC=C3
-
Synonyms
TAK-935 (Standard); OV935 (Standard)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. Toshiya Nishi, et al. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Sci Rep. 2020 Oct 13;10(1):17081. [Content Brief]
[2]. Krista Eschbach, et al. Stiripentol for the treatment of seizures in Dravet syndrome. Expert Rev Clin Pharmacol. 2019 May;12(5):379-388. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Soticlestat (Standard) Related Classifications
HY-109123R Related Classifications
Powered by Bioz